Articles On Global Health (ASX:GLH)

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Mernova secures first cannabis purchase order from Alberta Q3 revenues already breaking records with room for further growth Performance lays groundwork for strong second half in 2023   Melodiol Global Health (ASX:ME1) wholly-owned Canadi...

  ASX 200 find 0.5% to start the week, LTR looks ready to sell Energy stocks and miners offset IT and Consumer Discretionary losses Small cap winners led by EMD and GLH   Local markets were led higher on Monday, supported by resource busi...

Stockhead’s Top 10 at 11-ish, published once I’ve consumed enough coffee each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live (not frozen!) data. It’s a short, sharp update to help frame the tr...

Melodial Global Health welcomes moves to reschedule marijuana to a lower risk category in US Analyst says potential US policy change “could catalyse a significant re-rating of cannabis stocks” Melodial monitoring situation closely in even...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Melodial’s subsidiary Mernova looks to achieve significant quarter-on-quarter growth in Q3 Mernova also continues to advance compliance pathway for GMP certification Mernova continues to build its presence in Canada, which legalised cannab...

1st Group jumps 22pc after purchase order for its virtual healthcare system Austco Healthcare wins a $2.6m contract in Singapore Invex Therapeutic to shut down clinical trial immediately   Million dollar+ contracts for 1ST Group and Austc...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

The benchmark has sagged to -0.24% to close out the week with a world-weary sigh. Falling crude prices hobbled the Energy sector, dragging it 1.93% lower. Small caps winner Rubix Resources is feeling some neighbourly love, thanks to Allk...

Formerly Creso Pharma, Melodiol Global Health has a new name and a fresh drive to supply best-in-class psychedelic and cannabis products as it pursues growth in global markets. And the company is certainly chasing global growth, closing in...

A late surge from InfoTech pushed the benchmark to close at +0.07% InfoTech out front on +1.75%, ahead of Energy and Consumer Discretionary Huge news from Azure helped neighbour Errawarra into top spot for Small Caps   It’s the end of the...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

Melodiol Global Health have announced a non-binding Letter of Intent (LOI) to divest two of its business units – Sierra Sage Herbs (SSH) and Halucenex Life Sciences (Halucenex) – to US-based Panacea Life Sciences (OTCQB:PLSH) for an initial...

The ASX 200 put on a much better show today, with a +0.46% gain at closing time Sectors wise, Materials turned yesterday’s frown upside down Notable performers today: Pilbara Minerals; DXN; Si6 Metals; Strickland Metals   It’s been a much...

The ASX 200 closed -0.10% in the red today, after feeling flat all day Sectors wise, Energy stocks carried the torch with enthusiasm, while Materials wasn’t let anywhere near said torch Notable performers today: pharma stock Telix (ASX:TLX...

Melodiol Global Health’s wholly-owned Australian Subsidiary Health House (HHI) has demonstrated it’s heading in the right direction for the half ended 30 June 2023. Melodiol Global Health (ASX:ME1) closed the acquisition of HHI, an interna...

Lawyers for descendants of the late Peter Wright were first on the stand today, taking on Gina Rinehart over ownership and royalties relating to Hope Downs iron ore operations in the Pilbara. It’s day one of the Supreme Court of Western...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

What a time to be alive. As the clock struck midnight to herald the start of the 23/24 financial year, Australia’s ability to legally prescribe through qualified medical practitioners MDMA (ecstasy) and psilocybin – the active ingredient in...

After a strong start, the ASX levelled out as the market digested news there will be a new RBA Governor. The RBA will be led by a female for the first time, with deputy governor Michele Bullock replacing Phillip Lowe from September. ...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

The ASX 200 finishes up 1.56%  The ASX XEC rises 1.52% All 11 sectors were higher lead by Real Estate   The ASX 200 managed a decent 1.56% lift today, and the ASX XEC was also in the green, up 1.52%.  All of 11 sectors were higher, led b...

Melodial’s targeted M&A strategy is starting to pay off as its subsidiaries Heart Health International and Mernova boost revenue across the group to deliver a record quarter. Melodiol Global Health (ASX:ME1) has reported a material acc...

As demand grows for its range of recreational cannabis products, ME1 has recorded strong sales figures in the June quarter via a 42% increase on pcp in Q2 FY23. This also led Mernova to achieve a 20% revenue rise in H1 FY23 when compared to...

Health House Australia and UK operating units have become the second and third Melodiol Global Health subsidiaries to achieve a cash flow or adjusted EBITDA positive result. Melodiol Global Health Limited (ASX:ME1) has announced recent fin...

An already buoyant ASX boosted past +1.1% on happy CPI data for May. Consumer Discretionary just pipped by Real Estate, both up more than 2.1%. Stellar Resources takes line honours after hitting fresh zinc finds in Tassie.   A pleasing ba...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

ASX waddled to a -0.3% close, like a toddler with a turd in its trousers. Even the goldies retreated, with the XGD ASX All Ords Gold index dropping 0.20%. Blackmores sale is the most exciting thing to happen all day… which says it all, rea...

Telehealth specialist Global Health signs partnership deal with Woolworths subsidiary The deal will see Global Health provide virtual access to healthcare practitioners Orthocell hires experts to drive US market entry   Telehealth special...

Saturday March 11 was a typical balmy autumnal afternoon in Melbourne, but Neuren (ASX:NEU) chief Jon Pilcher was despondent as he awaited news from the company’s US partner Acadia on whether the US Food and Drug Administration (FDA) had ap...

The ASX 200 was up 0.39% and ASX XEC slips 0.42% 10 out of 11 sectors were higher lead by Communications The Real Estate sector was the only one in the red   The ASX 200 was up 0.39% today and the ASX XEC was down 0.42%.  A total of 10 ou...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Market goes out too hard, too early and beds down for a lengthy afternoon snooze Tempus Resources still riding high after drilling into phenomenally good gold grades Betting is now open on how long until the ASX’s next “how to announce stu...

The George Institute for Global Health has announced an agreement with the global investment firm, Hillhouse, for the purchase of George Clinical.

ASX 200 down 0.75%, dropping for the third straight day Small cap index falls 0.0.56% and 7 out 11 sectors finish lower China could reopen next year with ‘seismic’ implications for the rest of the world   The local bourse has dropped for...

ASX 200 down 0.55% on lower than normal volume  Small cap index falls 0.96% and 10 out 11 sectors finish lower Economy grows for the fourth consecutive quarter, up 0.6%    The ASX200 was down 0.55% today, and the ASX Emerging Companies...

ShareCafeSlowing Economic Growth and Three Sectors Set to Benefit What a year 2022 has been. From skyrocketing inflation and heightened geo-political tensions to global talent shortages and an energy crisis. But as the year draws to a close...

ASX 200 down -0.4% Small cap index loses -1.7%  Way2VAT: killing it in the VAT space The small caps index has been smashed on Monday as the local Energy and Resources Sectors took fright from what is easily the scariest social unrest acro...

The University of New South Wales announced 8 winners in the inaugural UNSW Founders Awards this week, recognising founders, startups and mentors for their outstanding contribution to innovation and the startup ecosystem. Virtual job simula...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

ASX200 weakens in arvo trade ASX small caps index sheds 0.3% Victory Goldfields is really, really winning REE   Just ahead of the close on Thursday, the S&P/ASX 200 was doing its best to shake off a decent session, despite most sector...

The University of NSW – the place where Atlassian’s Scott Farquhar and Mike Cannon-Brookes met – has announced its finalists for the inaugural UNSW Founders Awards. The awards, announced later this month at a gala dinner in Sydney on Novemb...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...